Related Experiment Video
Updated: Jul 17, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Health-Related Quality of Life in FKRP-Related Limb-Girdle Muscular Dystrophy R9
Synnøve M Jensen1,2, Oddgeir Friborg3, Svein Ivar Mellgren1,2
1National Neuromuscular Centre Norway and Department of Neurology, University Hospital of North Norway (UNN), Tromsø, Norway.
Limb-girdle muscular dystrophy R9 (LGMDR9) significantly impacts health-related quality of life (HRQoL), with progressive weakness and fatigue observed over 14 months. Targeted interventions for fatigue, pain, and sleep are crucial for managing LGMDR9.
Area of Science:
- Neurology
- Genetics
- Quality of Life Research
Background:
- Limb-girdle muscular dystrophy R9 (LGMDR9) is a progressive genetic muscle disorder caused by FKRP gene mutations.
- LGMDR9 can lead to severe disability, cardiomyopathy, and respiratory failure.
- Understanding the impact of LGMDR9 on health-related quality of life (HRQoL) is vital for patient care and treatment strategies.
Purpose of the Study:
- To assess HRQoL in the Norwegian LGMDR9 population over a 14-month period.
- To examine the relationship between HRQoL, fatigue, and sleep quality in LGMDR9 patients.
- To identify specific challenges and needs within the LGMDR9 patient cohort.
Main Methods:
- A cohort of 16+ year old Norwegian LGMDR9 patients participated in the study.
- Health-related quality of life was measured using the INQoL and SF-36 questionnaires at baseline, 8, and 14 months.
- Fatigue and sleep quality were assessed at 9 months.
Main Results:
- Compared to normative data, LGMDR9 patients exhibited impaired SF-36 scores, except for mental health in males and pain.
- Over 14 months, homozygotes showed worsening weakness and disease burden (INQoL index).
- Fatigue (40%) and poor sleep (49%) were prevalent, correlating with muscle weakness, pain, and mental distress.
Conclusions:
- A 14-month follow-up revealed progressive weakness and increased burden in LGMDR9 homozygotes.
- The high prevalence and impact of fatigue necessitate increased awareness and targeted treatment.
- Addressing myalgia, mental distress, sleep disturbances, and gender-specific needs is crucial for comprehensive LGMDR9 care.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
04:49Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
Published on: September 6, 2024